| |
November 15, 2004
Proposed addiction treatment successful, safe in second small trial
From Eureka Newsfeed:
A second, small-scale clinical trial of a proposed addiction treatment originally investigated at the U.S. Department of Energy's Brookhaven National Laboratory has produced favorable results in the treatment of long-term addiction to methamphetamine and/or cocaine, with no visual side effects in any of the 30 patients enrolled. This research on vigabatrin (a.k.a. gamma vinyl GABA, or GVG) is published in the February 2005 issue of Synapse, now available online. NYU School of Medicine Biochemical Psychiatry Fund; Catalyst Pharmaceutical Partners; NIH/National Institute on Drug Abuse; US Department of Energy Office of Science, Office of Biological and Environmental Research Read more from this post.
Posted on November 15, 2004 09:13 AM
|
Grassroots & Groundwork: What Communities are Doing to Get Out and Stay Out of Poverty
The Role of Medicaid and SCHIP as an Insurance Safety Net
An Overview of Selected Data on Children in Vulnerable Families
Anti-Poverty Practitioners Gear Up for Orlando Convention After Hurricane Katrina Shuts Down Their 2005 Meeting
|
